Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Smooth-Muscle Calcium and Vascular Contraction: Full Study

Previous related pageVitamin D, Smooth-Muscle Calcium and Vascular Contraction: Study SummaryNext related pageFrom Endothelial Signals to Smooth-Muscle Tone
Study at a glance

How might vitamin D affect muscle in blood-vessel walls?

This page examines how vitamin D-related changes affect the muscle in blood-vessel walls. The main experiments used artery pieces from rats and muscle cells from human placentas grown in the laboratory. They measured contraction under laboratory conditions, not the effects of supplements on blood pressure in people. Movement of calcium inside cells, muscle force and whole-body blood pressure are different measurements.

How did severe vitamin D depletion affect rat arteries?

After nine weeks of severe vitamin D depletion, isolated arteries contracted more strongly and responded to lower amounts of a contraction-triggering chemical. No significant difference was found after six weeks. The depleted rats also had low blood calcium, so the experiment could not separate a direct vitamin D effect from wider mineral changes. The artery result did not match a lasting difference in blood pressure.

How did active vitamin D affect human cells grown in the laboratory?

Active vitamin D reduced contraction of gels containing placental blood-vessel muscle cells over several days. It was not a test of an intact artery relaxing immediately. Changes in proteins involved in muscle control suggested a possible explanation, but the study did not prove that these changes caused the reduced contraction. It also did not measure calcium currents. The cells came from a specialised tissue, and repeated laboratory measurements were not equivalent to many independent donors.

Do these experiments establish a vitamin D treatment for blood pressure?

An earlier rat-cell report described increased calcium movement after active vitamin D exposure. Only its abstract was used here, so it provides limited background. The studies differ in species, tissues, treatments and timing; they do not show that vitamin D always lowers calcium inside cells or widens vessels. They do not establish a supplement dose, a blood-pressure treatment, a benefit in pregnancy or a treatment combination for people.

Read the full article below ↓

Vitamin D experiments can change vascular contraction without establishing a simple rule that vitamin D widens blood vessels. This review appraises an isolated rat-artery experiment and a human placental smooth-muscle cell experiment, with limited historical context on calcium currents. They measure different preparations, exposures and timescales. Their results help explain tone control but do not establish a blood-pressure treatment. For the shorter account, read Vitamin D, Smooth-Muscle Calcium and Vascular Contraction: Study Summary.

Calcium current, contractile force and vascular tone

The muscle layer of an artery can develop force and change the vessel’s resistance to blood flow. A calcium current is the movement of electrical charge carried by calcium ions through membrane channels. Cytosolic calcium is the free calcium concentration inside a cell. Neither measurement is identical to muscle force, vessel diameter or systemic blood pressure. The vascular tone overview provides the broader physiological setting for these distinct experimental questions.

Contraction depends on the interaction of actin and myosin, regulated in part by phosphorylation of myosin light chains. Enzymes that add or remove phosphate groups can alter contraction without a matching change in the amount of calcium entering the cell. Calcium availability outside the tissue also matters. The account of vitamin D and calcium physiology explains the wider mineral system; a serum calcium measurement cannot reveal a particular membrane-channel current.

An isolated artery retains a vessel wall with interacting cell types, whereas cultured smooth-muscle cells remove much of that context. Signals from the lining, described in endothelial function, can modify what the muscle does. Consequently, a force change in an artery does not by itself identify which cell compartment or molecular step produced it.

The rat experiment: dietary depletion and an isolated artery

Weishaar and Simpson studied male weanling Sprague-Dawley rats obtained from mothers receiving a low-vitamin-D diet. Animals were kept away from ultraviolet light. After initial measurements, they were randomly divided between vitamin-D-sufficient and deficient diets. The principal comparison used the same calcium and phosphorus content, 0.4% of each, and equal food allocations of 15 g per rat daily. The sufficient diet contained 2 IU vitamin D3 per gram; the deficient diet received the matching corn-oil vehicle.

This design reduced differences in food amount and the specified dietary minerals. It did not isolate vitamin D signalling within smooth muscle. Removing dietary vitamin D changed the animal’s systemic mineral physiology as well as its vitamin D exposure. Serum calcium fell markedly, and pooled samples showed vitamin D metabolites below assay detection after six and nine weeks. This is a severe depletion model, not a model of every modestly low vitamin D result in a human blood test.

The investigators studied tissues at six and nine weeks. Thoracic aortae were refrigerated overnight in physiological salt solution, then cut into rings approximately 3-4 mm long from a consistent location. Rings were suspended in a temperature-controlled bath, stretched to a standard resting tension and allowed to equilibrate. This standardisation matters because segment location, handling and resting load can change an artery’s measured force response.

After a potassium challenge and washout, increasing concentrations of noradrenaline, also called norepinephrine, were added. This constricting signal activates adrenergic receptors. The second concentration-response series was used for analysis because the first sometimes varied. Force was expressed relative to tissue wet weight, and a separate analysis expressed responses as a percentage of each preparation’s maximum. These two presentations distinguish response magnitude from sensitivity.

What changed after six and nine weeks?

At six weeks, the study did not detect a significant difference in the aortic response between dietary groups. The noradrenaline concentration producing half the maximum response, the EC50, was roughly 30 nM in both. Repeating this comparison with a lower bath calcium concentration did not reveal a sensitivity difference. This negative result is part of the evidence; it should not disappear from an account centred on the later positive finding.

At nine weeks, the deficient animals’ aortae responded more strongly and at lower noradrenaline concentrations. The reported EC50 was 9 nM in the deficient group and 25 nM in the sufficient group. A lower EC50 means greater sensitivity within this assay, rather than a lower blood vitamin D threshold. Reported maximum force was 0.542 ± 0.038 versus 0.258 ± 0.027 grams of tension per milligram wet tissue weight, respectively. The uncertainty values are standard errors, not confidence intervals or ranges across individual animals.

The relevant figures report four to six rings per group and statistically significant group differences at nine weeks, but not six weeks. A ring count must not silently become an animal count; the reported figure sample sizes do not fully specify the number of independent animals behind each curve. The paper used analysis of variance for response curves and unpaired tests for several circulating and physiological measures. It provides no confidence interval for the between-group vascular effect.

The late increase in isolated-vessel force also did not track sustained hypertension. Tail-cuff systolic pressure initially rose more in the deficient group, but the reported group difference had disappeared by eight weeks. Thus, the same experiment demonstrates a useful limit: an altered response in an excised aorta cannot be treated as a direct reading of blood pressure in the whole animal.

What the calcium comparison can and cannot establish

The investigators also tested a diet with higher calcium and phosphate that brought serum calcium closer to normal during vitamin D depletion. However, the reported functional rescue comparison involved isolated hearts. It was not a corresponding demonstration that the aortic effect persisted after mineral correction. Importing that cardiac result into the vascular experiment would overstate the evidence for a direct action on vascular smooth muscle.

Indeed, the authors left the direct versus indirect explanation of the vascular findings unresolved and discussed a possible contribution from low calcium. Their mention of preliminary work was not a published result within this paper. The current vascular data establish a changed response after the depletion regimen, but do not separate receptor signalling from all systemic consequences of that regimen. The receptor overview explains a possible route of action; receptor involvement still requires an appropriate experiment.

Other limits are specific to the preparation. The aorta is a large elastic artery, not a small resistance vessel. The study did not directly record calcium-channel currents, cytosolic calcium or endothelial mediator release in these rings. Random group allocation is reported, but detailed allocation concealment and blinded force analysis are not described. These limitations narrow the mechanistic conclusion without cancelling the observed force difference.

The human-cell experiment: contraction in a collagen gel

Jia and colleagues isolated smooth-muscle cells from tertiary chorionic plate arteries of normal term human placentas. Cells at passages three to five were used. Their marker staining supported a smooth-muscle identity and absence of the endothelial marker CD31. These were cultured cells from a specialised vascular bed, not patients receiving a supplement and not intact placental arteries carrying blood.

The investigators mixed cells with collagen to form floating gels. Cells could pull on and compact the gel, allowing contraction to be assessed from its changing surface area. For the contraction experiment, cells were pretreated with 100 nM calcitriol for 24 hours. Calcitriol is active 1,25-dihydroxyvitamin D3; it is distinct from nutritional vitamin D3 and from circulating 25-hydroxyvitamin D used to assess status.

Six conditions compared untreated cells, angiotensin II alone, losartan plus angiotensin II, calcitriol alone, calcitriol plus angiotensin II, and all three agents. Angiotensin II was used at 10−7 M and losartan at 10−4 M. These are experimental concentrations, not clinical dosing instructions. Treatments were added every 24 hours and gel areas were followed for seven days.

Contraction was calculated from the loss of gel area relative to its starting area, then normalised to the untreated control within the experiment. The control’s day-seven contraction was set to 100%. This does not mean that the control gel lost all its area, or that a result of 89% means a vessel narrowed by 89%. The normalisation is essential to interpreting the numbers.

Day-seven conditionReported contraction relative to untreated control
Untreated control100% by definition
Angiotensin II105%
Losartan plus angiotensin II76%
Calcitriol alone87%
Calcitriol plus angiotensin II89%
Calcitriol, losartan and angiotensin II66%

The results came from five independent contraction experiments, each with triplicate wells per condition. Triplicate wells are repeated measurements within an experiment, not three independent donors. The report does not establish that the five experiments represent five distinct placental donors. Means and standard errors were presented; exact confidence intervals for treatment differences were not supplied.

The calcitriol-plus-angiotensin-II condition showed less contraction than angiotensin II alone, and adding calcitriol to the losartan condition reduced contraction further. The article reports the relevant comparisons as statistically significant. It does not establish pharmacological synergy from a formal interaction analysis. Nor does the assay show an already contracted artery immediately relaxing: it measures cumulative gel contraction over days.

A proposed mechanism involving myosin phosphatase

In parallel protein experiments, calcitriol increased vitamin D receptor expression and changed expression of enzymes involved in vitamin D metabolism. Presence of these proteins suggests capacity for local regulation, but the study did not directly measure vitamin D synthesis in the cells. Protein abundance is not the same measurement as metabolic flux.

Angiotensin II increased ROCK1 protein expression, and this increase was attenuated with losartan or calcitriol. ROCK1 is part of a pathway that can influence the contractile machinery. Phosphorylation of MYPT1 at serine 507 also increased in relevant treatment conditions. MYPT1 helps regulate myosin light-chain phosphatase, an enzyme system involved in removing phosphate groups from myosin light chains and reducing contraction.

The pattern was selective. Total RhoA and MYPT1 protein did not differ detectably; the measured angiotensin receptor proteins did not show the proposed treatment effect; serine-668 phosphorylation did not show the same increase. Two examined threonine phosphorylation sites were undetectable. Undetectable signal is not proof that the relevant molecules never function in these cells.

These findings support a plausible pathway, but they do not prove that the protein changes caused the gel result. The study did not directly demonstrate the proposed change in phosphatase enzyme activity or eliminate the functional effect by selectively disrupting that pathway. It also did not measure calcium currents. The mechanism should therefore remain an interpretation supported by associated measurements.

Where the earlier calcium-current evidence fits

Shan and colleagues reported increased calcium-channel current and cytosolic calcium after adding active vitamin D to rat tail-artery-derived smooth-muscle cells. That qualitative finding comes from the primary abstract, which describes patch-clamp and fluorescence measurements. The complete paper was not available for this appraisal, so its numerical estimates, detailed controls and robustness are not assessed here. It is historical context rather than a third fully appraised experiment.

The direction of that report is a reason to avoid assuming that vitamin D always reduces intracellular calcium or immediately relaxes every vascular preparation. It is not a contradiction that can be resolved simply by choosing a preferred study. Acute exposure in rat arterial cells, weeks of dietary depletion in a growing animal and prolonged exposure in cultured human placental cells are different biological interventions.

What these experiments establish

The strongest common conclusion concerns experimental responsiveness: vitamin D-related manipulations can accompany changes in arterial force or cultured smooth-muscle contraction under specified conditions. The evidence hierarchy helps distinguish that conclusion from a clinical treatment effect. Human origin of cultured cells does not make an experiment a human supplementation trial.

The distinction between vitamin D status and biological effect is equally important. Neither a bath concentration nor a severe rodent depletion regimen provides a target for a routine blood test. These experiments do not establish an oral supplement dose, a benefit in pregnancy, a treatment combination with losartan or prevention of cardiovascular events.

Within heart and circulatory physiology, smooth-muscle force is one component of a larger system. The useful next questions are which cellular step changes, whether the finding survives controls for minerals and tissue preparation, and whether a corresponding effect appears in intact human circulation. Those questions preserve the value of the laboratory findings while keeping their clinical meaning proportionate.

Scientific sources

Weishaar RE, Simpson RU. Vitamin D3 and cardiovascular function in rats. Journal of Clinical Investigation. 1987;79(6):1706-1712. DOI: 10.1172/JCI113010. PMID: 3034981. Full-paper appraisal focused on the vascular experiment; the separate cardiac calcium-rescue experiment is distinguished.

Jia X, Gu Y, Groome LJ, Al-Kofahi M, Alexander JS, Li W, Wang Y. 1,25(OH)2D3 Induces Placental Vascular Smooth Muscle Cell Relaxation by Phosphorylation of Myosin Phosphatase Target Subunit 1Ser507: Potential Beneficial Effects of Vitamin D on Placental Vasculature in Humans. Biology of Reproduction. 2016;94(5):116, 1-8. DOI: 10.1095/biolreprod.116.138362. PMID: 27075619. Cultured human placental smooth-muscle experiment.

Shan J, Resnick LM, Lewanczuk RZ, Karpinski E, Li B, Pang PK. 1,25-Dihydroxyvitamin D as a Cardiovascular Hormone Effects on Calcium Current and Cytosolic Free Calcium in Vascular Smooth Muscle Cells. American Journal of Hypertension. 1993;6(12):983-988. DOI: 10.1093/ajh/6.12.983. PMID: 8136098. Qualitative historical context from the primary abstract, not a full-paper appraisal.

Related reading

Original sources

Source

Vitamin D3 and cardiovascular function in rats

Published in Journal of Clinical Investigation (1987).

Publication details

Weishaar RE, Simpson RU. Vitamin D3 and cardiovascular function in rats. Journal of Clinical Investigation. 1987;79(6):1706-1712. DOI: 10.1172/JCI113010. PMID: 3034981. Full-paper appraisal focused on the vascular experiment; the separate cardiac calcium-rescue experiment is distinguished.

Read more →
Source

1,25(OH)2D3 Induces Placental Vascular Smooth Muscle Cell Relaxation by Phosphorylation of Myosin Phosphatase Target Subunit 1Ser507: Potential Beneficial Effects of Vitamin D on Placental Vasculature in Humans

Published in Biology of Reproduction (2016).

Publication details

Jia X, Gu Y, Groome LJ, Al-Kofahi M, Alexander JS, Li W, Wang Y. 1,25(OH)2D3 Induces Placental Vascular Smooth Muscle Cell Relaxation by Phosphorylation of Myosin Phosphatase Target Subunit 1Ser507: Potential Beneficial Effects of Vitamin D on Placental Vasculature in Humans. Biology of Reproduction. 2016;94(5):116, 1-8. DOI: 10.1095/biolreprod.116.138362. PMID: 27075619. Cultured human placental smooth-muscle experiment.

Read more →
Source

1,25-Dihydroxyvitamin D as a Cardiovascular Hormone Effects on Calcium Current and Cytosolic Free Calcium in Vascular Smooth Muscle Cells

Published in American Journal of Hypertension (1993).

Publication details

Shan J, Resnick LM, Lewanczuk RZ, Karpinski E, Li B, Pang PK. 1,25-Dihydroxyvitamin D as a Cardiovascular Hormone Effects on Calcium Current and Cytosolic Free Calcium in Vascular Smooth Muscle Cells. American Journal of Hypertension. 1993;6(12):983-988. DOI: 10.1093/ajh/6.12.983. PMID: 8136098. Qualitative historical context from the primary abstract, not a full-paper appraisal.

Read more →